Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

HYDROMORPHONE Safety Reports

Total HYDROMORPHONE reports: 156.
HYDROMORPHONE FDA safety alerts: 2002 2005 .
Reported deaths: 83    Reported hospitalizations: 34.
Take HYDROMORPHONE Side Effects Survey or Share Your HYDROMORPHONE Story. Read More Here.

Showing 1-75 of 156 Next >

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 15, 2006. Male patient, 27 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with BENZOYLECGONINE, ETHANOL. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 15, 2006. Male patient, 45 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: contusion, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with VALPROIC ACID. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 15, 2006. Male patient, 32 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: completed suicide. HYDROMORPHONE dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 15, 2006. Female patient, 41 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: metastatic carcinoma of the bladder, pneumonia. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 15, 2006. Female patient, 55 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, coronary artery disease. HYDROMORPHONE dosage: unknown. During the same period patient was treated with SERTRALINE, HYDROMORPHONE CONTIN. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 08, 2006. Male patient, 52 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: bronchial carcinoma, metastases to central nervous system, metastases to heart, metastases to liver, metastases to lung, metastases to lymph nodes, metastases to spine, metastatic neoplasm, myocardial infarction. HYDROMORPHONE dosage: unknown. During the same period patient was treated with NAPROXEN. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 08, 2006. Male patient, 51 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: metastatic renal cell carcinoma, pulmonary embolism. HYDROMORPHONE dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE, LORAZEPAM. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 08, 2006. Female patient, 58 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pneumonia. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 08, 2006. Female patient, 41 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: metastatic carcinoma of the bladder, pneumonia. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 08, 2006. Female patient, 43 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, asphyxia, petechiae, pulmonary congestion. HYDROMORPHONE dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 15, 2006. Male patient, 65 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning. HYDROMORPHONE dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 15, 2006. Male patient, 38 years of age, was treated with HYDROMORPHONE. HYDROMORPHONE dosage: unknown. During the same period patient was treated with SECOBARBITAL, NORDIAZEPAM. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 08, 2006. Male patient, 42 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: aspiration, pulmonary congestion, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with ETHANOL, DIPHENHYDRAMINE, DILTIAZEM. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 08, 2006. Male patient, 48 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: aspiration, depressed level of consciousness, myocardial ischaemia, pulmonary congestion. HYDROMORPHONE dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 08, 2006. Male patient, 27 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: foaming at mouth, increased bronchial secretion, pneumonia aspiration, pulmonary congestion, pulmonary haemorrhage, pulmonary oedema. HYDROMORPHONE dosage: unknown. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 08, 2006. Male patient, 45 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: contusion, convulsion, coronary artery disease. HYDROMORPHONE dosage: unknown. During the same period patient was treated with VALPROIC ACID. Patient died.

Physician from CANADA reported HYDROMORPHONE problem on Aug 08, 2006. Male patient, 48 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: injection site bruising, pulmonary congestion, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DIAZEPAM, NORDAZEPAM, OXAZEPAM, ETHANOL. Patient died.

HYDROMORPHONE problem was reported by a Physician from CANADA on Aug 08, 2006. Male patient, 59 years of age, was diagnosed with pain management and was treated with HYDROMORPHONE. HYDROMORPHONE dosage: unknown. Patient died.

Physician from UNITED STATES reported HYDROMORPHONE problem on Aug 15, 2006. Male patient, 48 years of age, was diagnosed with back pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: injection site mass, meningioma, muscular weakness. HYDROMORPHONE dosage: unknown. During the same period patient was treated with BUPIVACAINE. Patient was hospitalized. Patient recovered.

HYDROMORPHONE problem was reported by a Physician from UNITED STATES on Aug 24, 2006. Male patient, 48 years of age, was diagnosed with back pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: injection site mass. HYDROMORPHONE dosage: 41MG/DAY INTRATHECAL PUMP, INTRATHECAL. During the same period patient was treated with BUPIVACAINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HYDROMORPHONE problem on Aug 31, 2006. Female patient, weighting 178.6 lb, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. HYDROMORPHONE dosage: 0.25MG Q3H IV (DURATION: ONE DOSE). Patient recovered.

HYDROMORPHONE problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Female patient, 15 years of age, was diagnosed with pain management, antiemetic supportive care, antibiotic prophylaxis and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dyspnoea, incorrect dose administered, urticaria. HYDROMORPHONE dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, DEMEROL, MORPHINE SULPHATE, ANTIMICROBIAL, OXYCODONE, CODEINE SUL, PROPOXYPHENE. Patient recovered.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Male patient, 42 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: aspiration, pulmonary congestion, pulmonary oedema, vomiting. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DILTIAZEM, DIPHENHYDRAMINE. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 45 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: contusion, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with VALPROIC ACID. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Female patient, 22 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: haemorrhage subcutaneous, pulmonary oedema, puncture site haemorrhage. HYDROMORPHONE dosage: unknown. During the same period patient was treated with MORPHINE, DIAZEPAM. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 51 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, hepatic failure, lung disorder. HYDROMORPHONE dosage: unknown. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Male patient, 42 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pulmonary congestion, pulmonary oedema, vomiting. HYDROMORPHONE dosage: unknown. During the same period patient was treated with VALPROIC ACID, GABAPENTIN. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 51 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LORAZEPAM, MORPHINE. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Female patient, 28 years of age, was diagnosed with completed suicide and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: completed suicide, injection site haemorrhage, injection site inflammation. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 29 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: epistaxis, foreign body trauma, gait disturbance, pulmonary congestion, rhinorrhoea, somnolence. HYDROMORPHONE dosage: unknown. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Male patient, 37 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, narcotic intoxication, pulmonary congestion, venipuncture site swelling. HYDROMORPHONE dosage: unknown. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 38 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, narcotic intoxication, pulmonary congestion. HYDROMORPHONE dosage: unknown. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Male patient, 34 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, narcotic intoxication, pulmonary congestion. HYDROMORPHONE dosage: unknown. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 38 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pulmonary congestion, pulmonary necrosis, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DIAZEPAM, SECOBARBITAL. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Male patient, 31 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: blood alcohol increased, pulmonary congestion, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DIAZEPAM, DOXEPIN, FENTANYL. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 48 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: injection site bruising, narcotic intoxication, pulmonary congestion, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DIAZEPAM, OXAZEPAM. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Female patient, 43 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: asphyxia, fall, narcotic intoxication, petechiae, pulmonary congestion. HYDROMORPHONE dosage: unknown. During the same period patient was treated with MEPERIDINE, DIAZEPAM. Patient died.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from CANADA on Aug 25, 2006. Male patient, 14 years of age, was diagnosed with completed suicide and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: completed suicide, narcotic intoxication, pneumonia, pulmonary congestion. HYDROMORPHONE dosage: unknown. Patient died.

Consumer or non-health professional from CANADA reported HYDROMORPHONE problem on Aug 25, 2006. Male patient, 59 years of age, was diagnosed with pain management and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: bone neoplasm, brain oedema, multiple myeloma, pulmonary oedema, renal failure. HYDROMORPHONE dosage: unknown. Patient died.

HYDROMORPHONE problem was reported by a Physician from CANADA on Aug 25, 2006. Male patient, 41 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, pulmonary congestion. HYDROMORPHONE dosage: unknown. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 24, 2006. Male patient, 48 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, aspiration, loss of consciousness, myocardial ischaemia, pulmonary congestion. HYDROMORPHONE dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 24, 2006. Male patient, 52 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: bronchial carcinoma, metastatic neoplasm, myocardial infarction. HYDROMORPHONE dosage: unknown. During the same period patient was treated with NAPROXEN. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 24, 2006. Female patient, 55 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, coronary artery disease, overdose, pulmonary oedema. HYDROMORPHONE dosage: unknown. During the same period patient was treated with HYDROMORPHONE HYDROCHLORIDE, SERTRALINE. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from CANADA on Aug 24, 2006. Female patient, 58 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pneumonia. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient died.

Health Professional from CANADA reported HYDROMORPHONE problem on Aug 24, 2006. Male patient, 27 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration, pulmonary congestion, pulmonary haemorrhage, pulmonary oedema. HYDROMORPHONE dosage: unknown. Patient died.

HYDROMORPHONE problem was reported by a Physician from UNITED STATES on May 09, 2006. Male patient, weighting 228.4 lb, was diagnosed with migraine prophylaxis, transient ischaemic attack, breakthrough pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: euphoric mood, fatigue, hypotension, overdose, respiratory distress, suicide attempt, unresponsive to stimuli. HYDROMORPHONE dosage: unknown. During the same period patient was treated with HYDROMORPHONE HYDROCHLORIDE, DEPAKOTE, KADIAN, ORAVESCENT FENTANYL CITRATE, CLONIDINE, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported HYDROMORPHONE problem on Sept 14, 2006. Male patient, 62 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: aggression, delirium. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LORAZEPAM, OXYCODONE AND ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

HYDROMORPHONE problem was reported by a Pharmacist from UNITED STATES on Sept 19, 2006. Female patient, 52 years of age, weighting 306.4 lb, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood pressure diastolic increased, cardio-respiratory arrest, cholecystitis, cholelithiasis, lipase increased, overdose, refusal of treatment by patient, renal failure acute. HYDROMORPHONE dosage: 4 MG IV OTO. During the same period patient was treated with MORPHINE, ZOFRAN, LEVAQUIN, FLAGYL, LISINOPRIL, HYDROCHLOROTHIAZIDE, METFORMIN, NORVASC. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HYDROMORPHONE problem on Sept 21, 2006. Female patient, 57 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, muscle rigidity, posturing. HYDROMORPHONE dosage: 2 MG IV PRN. Patient recovered.

HYDROMORPHONE problem was reported by a Health Professional from UNITED STATES on Sept 26, 2006. Female patient, 52 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. HYDROMORPHONE dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported HYDROMORPHONE problem on Oct 11, 2006. Male patient, 78 years of age, weighting 138.9 lb, was diagnosed with neuralgia and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: dementia. HYDROMORPHONE dosage: 4-10MG Q3H PO. Patient was hospitalized. Patient recovered.

HYDROMORPHONE problem was reported by a Pharmacist from UNITED STATES on Oct 13, 2006. Male patient, 29 years of age, weighting 141.0 lb, was diagnosed with pain, nausea and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, respiratory arrest. HYDROMORPHONE dosage: 2 MG ONCE IV BOLUS 1 DOSE. During the same period patient was treated with PROMETHAZINE, ERYTHROMYCIN, ONDANSETRON, ESCITALOPRAM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HYDROMORPHONE problem on Oct 17, 2006. Female patient, 52 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. HYDROMORPHONE dosage: 2 MG IV EVERY 4 HOURS. Patient recovered.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from on Aug 28, 2006. Male patient, 71 years of age, was diagnosed with cancer pain, metastatic neoplasm and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: jaundice, rash. HYDROMORPHONE dosage: unknown. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HYDROMORPHONE problem on July 24, 2006. Female patient, 54 years of age, was diagnosed with back pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: anaphylaxis treatment, bradycardia, dyspnoea, hypotension, urticaria. HYDROMORPHONE dosage: 2 MG PO PRN. During the same period patient was treated with OMEPRAZOLE, BENADRYL, AMBIEN. Patient recovered.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardio-respiratory arrest, completed suicide. HYDROMORPHONE dosage: unknown. During the same period patient was treated with MORPHINE, ALPRAZOLAM. Patient died.

Consumer or non-health professional from UNITED STATES reported HYDROMORPHONE problem on Oct 30, 2006. Female patient, 26 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardio-respiratory arrest, completed suicide. HYDROMORPHONE dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

HYDROMORPHONE problem was reported by a Health Professional from UNITED STATES on Nov 17, 2006. Female patient, 32 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, depressed level of consciousness, miosis, musculoskeletal stiffness, pallor, post procedural complication, pulse absent. HYDROMORPHONE dosage: 1 MILLIGRAM/MILLILITERS, 0.2 MG PCA, 8 MIN LOCKOUT, 5MG 4HR LIMIT, INTRAVENOUS. During the same period patient was treated with MORPHINE SULPHATE, TORADOL. Patient recovered.

Pharmacist from CANADA reported HYDROMORPHONE problem on Sept 06, 2006. Female patient, 53 years of age, was diagnosed with haemorrhage and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: burning sensation, nerve injury, pain. HYDROMORPHONE dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR, FENTANYL, GRAVOL. Patient was hospitalized. Patient recovered.

HYDROMORPHONE problem was reported by a Physician from GERMANY on Nov 27, 2006. Female patient, 38 years of age, weighting 158.1 lb, was diagnosed with pain, depression and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: narcotic intoxication, pulmonary haemorrhage. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LEXAPRO, DIPHENHYDRAMINE, ETHANOL, PROMETHAZINE. Patient died on 05/01/2004.

Consumer or non-health professional from UNITED STATES reported HYDROMORPHONE problem on Dec 06, 2006. Male patient, 49 years of age, weighting 228.6 lb, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: dizziness, orthostatic hypotension. HYDROMORPHONE dosage: unknown. Patient recovered.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Female patient was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, loss of consciousness. HYDROMORPHONE dosage: unknown. During the same period patient was treated with DILAUDID. Patient died on 11/19/2006.

Physician from GERMANY reported HYDROMORPHONE problem on Nov 27, 2006. Female patient, 38 years of age, weighting 158.1 lb, was diagnosed with pain, depression, nausea, vomiting and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: narcotic intoxication, pulmonary haemorrhage. HYDROMORPHONE dosage: unknown. During the same period patient was treated with LEXAPRO, DIPHENHYDRAMINE, ETHANOL, PROMETHAZINE. Patient died on 05/01/2004.

HYDROMORPHONE problem was reported by a Pharmacist from UNITED STATES on Dec 02, 2006. Male patient, 55 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: myoclonus. HYDROMORPHONE dosage: 4 MG TOTAL IV. During the same period patient was treated with DISOPYRAMIDE, ATENOLOL, ENALAPRIL MALEATE, WARFARIN, EXTENDED, GABAPENTIN, SIMVASTATIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HYDROMORPHONE problem on Dec 22, 2006. Female patient, 17 years of age, weighting 149.9 lb, was diagnosed with abdominal pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: rash pruritic. HYDROMORPHONE dosage: 2MG ONCE IV. Patient was hospitalized. Patient recovered.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from on June 25, 2007. Male patient was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: accidental exposure. HYDROMORPHONE dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE. Patient died on 01/01/2005.

Consumer or non-health professional from reported HYDROMORPHONE problem on June 27, 2007. Female patient, 75 years of age, was diagnosed with postoperative analgesia and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction, dyspnoea, respiratory distress, treatment failure, wheezing. HYDROMORPHONE dosage: 1 MG Q4H PRN X 2 DOSES. During the same period patient was treated with MORPHINE, FUROSEMIDE, ANGIOTENSIN, STATIN, ASPIRIN. Patient was hospitalized. Patient recovered.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from on June 25, 2007. Male patient was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: accidental exposure. HYDROMORPHONE dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE. Patient died on 01/01/2005.

Consumer or non-health professional from UNITED STATES reported HYDROMORPHONE problem on July 10, 2007. Female patient, 75 years of age, was diagnosed with procedural pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. HYDROMORPHONE dosage: 1 MG, Q4H PRN. During the same period patient was treated with VANCOMYCIN, FUROSEMIDE, ACE INHIBITOR NOS, STATIN, ASPIRIN. Patient recovered.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from on July 18, 2007. Female patient was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: asphyxia, victim of homicide. HYDROMORPHONE dosage: UNK MG, UNK. During the same period patient was treated with XANAX, HYDROCODONE BITARTRATE. Patient died on 06/22/2007.

Physician from UNITED STATES reported HYDROMORPHONE problem on July 23, 2007. Female patient, 75 years of age, was diagnosed with procedural pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction, respiratory distress, stridor, wheezing. HYDROMORPHONE dosage: 1 MG, EVERY 4 HOURS, INTRAVENOUS. During the same period patient was treated with MORPHINE. Patient recovered.

HYDROMORPHONE problem was reported by a Pharmacist from UNITED STATES on Aug 02, 2007. Female patient, 56 years of age, was diagnosed with pain and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, nausea, respiratory depression, somnolence. HYDROMORPHONE dosage: 540MG ONCE SQ. During the same period patient was treated with CLONIDINE, LANTUS, LISINOPRIL, METHADONE, AMBIEN, CLOAZEPAM, ADVAIR DISKUS, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HYDROMORPHONE problem on Aug 10, 2007. Female patient, 45 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: completed suicide. HYDROMORPHONE dosage: unknown. During the same period patient was treated with VERAPAMIL, METAXALONE. Patient died on 01/01/2000.

HYDROMORPHONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2007. Female patient, 45 years of age, was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, completed suicide. HYDROMORPHONE dosage: unknown. During the same period patient was treated with VERAPAMIL, METAXALONE. Patient died on 01/01/2000.

Physician from UNITED STATES reported HYDROMORPHONE problem on Aug 07, 2007. Female patient was diagnosed with procedural pain, pain management, wound infection staphylococcal and was treated with HYDROMORPHONE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, respiratory distress. HYDROMORPHONE dosage: 1 MG, Q4H. During the same period patient was treated with MORPHINE, FUROSEMIDE, ANGIOTENSIN II ANTAGONISTS, HMG COA REDUCTASE INHIBITORS, ASPIRIN, VANCOMYCIN. Patient recovered.

Showing 1-75 of 156 Next >